Edaravone dexborneol compared to edaravone in the treatment of acute cerebral infarction: A meta-analysis

Edaravone dexborneol compared to edaravone in the treatment of acute cerebral infarction: A meta-analysis

ObjectiveThe objective of this study was to systematically assess the clinical efficacy and safety of edaravone dexborneol compared to those of edaravone in treating acute cerebral infarction.MethodsWe searched the PubMed, Cochrane Library, Embase, CBM, CNKI, Wanfang Database, and VIP to gather rand...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanshuo Shi, Yuanyuan Yue, Mi Wang, Huizhen Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Pharmacology
Subjects:	PubMed Cochrane Library Embase CBM CNKI Wanfang, edaravone dexborneol
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1579742/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Edaravone dexborneol provides neuroprotective benefits by suppressing ferroptosis in experimental intracerebral hemorrhage
by: Han Li, et al.
Published: (2025-05-01)

Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage
by: Qian Chen, et al.
Published: (2022-04-01)

Corrigendum: Edaravone dexborneol treatment attenuates neuronal apoptosis and improves neurological function by suppressing 4-HNE-associated oxidative stress after subarachnoid hemorrhage
by: Qian Chen, et al.
Published: (2024-12-01)

Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease
by: Qingrui Duan, et al.
Published: (2025-02-01)

Edaravone Dexborneol provides neuroprotective effect by inhibiting neurotoxic activation of astrocytes through inhibiting NF-κB signaling in cortical ischemia
by: Zhe Chen, et al.
Published: (2024-11-01)

Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe/PS1dE9 mice
by: Rui Mao, et al.
Published: (2025-06-01)

Edaravone dexborneol protected neurological function by targeting NRF2/ARE and NF-κB/AIM2 pathways in cerebral ischemia/reperfusion injury
by: Hui Zhang, et al.
Published: (2025-04-01)

A Technical Note on Bibliometric Analysis by Biblioshiny and VOSviewer
by: Himel Mondal

Anti-Cancer Drugs: Trends and Insights from PubMed Records
by: Ferdinando Spagnolo, et al.
Published: (2025-05-01)

SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Edaravone's Safety Profile in Acute Ischemic Stroke
by: Laurence K. J. Batino, et al.
Published: (2024-12-01)

PuMA: PubMed gene/cell type-relation Atlas
by: Lucas Bickmann, et al.
Published: (2025-07-01)

Algorithmic indexing in MEDLINE frequently overlooks important concepts and may compromise literature search results
by: Alexandre Amar-Zifkin, et al.
Published: (2025-01-01)

Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats
by: Ozlem Kara, et al.
Published: (2024-01-01)

Suicidology Needs a More Inclusive Approach for Low and Middle‐Income Countries
by: S. M. Yasir Arafat, et al.
Published: (2025-06-01)

A Comparative Analysis of Sentence Transformer Models for Automated Journal Recommendation Using PubMed Metadata
by: Maria Teresa Colangelo, et al.
Published: (2025-03-01)

A PubMed search filter for efficiently retrieving exercise training studies
by: Dawei Yin, et al.
Published: (2024-12-01)

Research hotspots in pediatrics: co-word clustering analysis based on readership in PubMed Central
by: Fangming Deng, et al.
Published: (2024-10-01)

Development and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification
by: Riuna O’Neill, et al.
Published: (2025-07-01)

Machine learning and artificial intelligence based Diabetes Mellitus detection and self-management: A systematic review
by: Jyotismita Chaki, et al.
Published: (2022-06-01)

The protective effect of Edaravone against acute renocardiac syndrome in a kidney ischemia-reperfusion model
by: Yasin Bagheri, et al.
Published: (2024-12-01)

Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis
by: Chang Liu, et al.
Published: (2024-10-01)

BASIL DB: bioactive semantic integration and linking database
by: David Jackson, et al.
Published: (2025-08-01)

The effect of Edaravone on clinical symptoms and oxidative stress factors in patients with acute ischemic stroke: A clinical trial
by: Mojtaba Khazaei, et al.
Published: (2024-04-01)

Edaravone Attenuates Sleep Deprivation-Induced Memory Deficits by Inhibiting Oxidative Stress and Neuroinflammation in Murine Models
by: Shiliang Ji, et al.
Published: (2025-04-01)

Adverse events reporting of edaravone: a real-world analysis from FAERS database
by: Qi Shang, et al.
Published: (2025-03-01)

Association between edaravone use and activities of daily living in older patients with atherothrombotic stroke: an observational study using Japanese real-world data
by: Yukari Ogawa, et al.
Published: (2025-01-01)

Edaravone reduces the markers of oxidative stress and neuroinflammation in neocortex of rats with acute intracerebral hemorrhage and type 2 diabetes mellitus
by: V. L. Holubiev, et al.
Published: (2024-12-01)

Neuroprotective effect and possible mechanism of edaravone in rat models of spinal cord injury: a systematic review and network meta-analysis
by: Long-yun Zhou, et al.
Published: (2025-04-01)

Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
by: Yuanxiang Huang, et al.
Published: (2022-01-01)

Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysis
by: James D Berry, et al.
Published: (2025-01-01)

Prevalence of Tic Disorders: a Meta-Analysis
by: J Gordon Millichap
Published: (2012-08-01)

Solicitud de indexación en PubMed
by: Ernesto Bersusky
Published: (2025-06-01)

Protective Effect of Edaravone on Glutamate-Induced Neurotoxicity in Spiral Ganglion Neurons
by: Xiaohui Bai, et al.
Published: (2016-01-01)

TUBERCULOSIS PREVENTIVE THERAPY AS A STRATEGY TO PREVENT AND CONTROL TUBERCULOSIS INCIDENCE 2010-2024: A BIBLIOMETRIC ANALYSIS
by: Yunita Sari, et al.
Published: (2025-05-01)

Investigating a role for PUB17 and PUB16 in the self‐incompatibility signaling pathway in transgenic Arabidopsis thaliana
by: Paula K. S. Beronilla, et al.
Published: (2024-07-01)

A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of edaravone in ischemic stroke
by: Lin Guo, et al.
Published: (2021-02-01)

Peculiarities of neuroprotective therapy in women with acute ischemic stroke
by: O. A. Halushko, et al.
Published: (2020-08-01)

A Comprehensive Bibliometric Analysis of Brucellosis Research: Insights from CNKI and Web of Science Databases (2014-2023)
by: Wang J, et al.
Published: (2025-05-01)

Research Progress of Comprehensive Control of Small Watershed in China Based on Bibliometrics Analysis
by: WEI Caiyong, et al.
Published: (2021-01-01)